US 12,225,917 B2
Berberine alkaloid formulations in the prevention and/or treatment of infectious disease
David Xiang Yu, Frankston South (AU); Zhicheng Xiao, Langwarrin (AU); Colin William Pouton, Alphington (AU); and Zhiyong He, Pakenham (AU)
Assigned to IRP HEALTH PTY LTD, Mount Waverly (AU)
Appl. No. 16/499,163
Filed by IRP Health Pty Ltd, Mount Waverley (AU)
PCT Filed Mar. 28, 2018, PCT No. PCT/AU2018/050288
§ 371(c)(1), (2) Date Sep. 27, 2019,
PCT Pub. No. WO2018/176093, PCT Pub. Date Oct. 4, 2018.
Claims priority of application No. 2017901105 (AU), filed on Mar. 28, 2017; and application No. 2017903261 (AU), filed on Aug. 15, 2017.
Prior Publication US 2021/0329946 A1, Oct. 28, 2021
Int. Cl. A23K 20/132 (2016.01); A23K 50/30 (2016.01); A23K 50/75 (2016.01); A61K 9/00 (2006.01); A61K 31/4375 (2006.01); A61P 31/04 (2006.01)
CPC A23K 20/132 (2016.05) [A23K 50/30 (2016.05); A23K 50/75 (2016.05); A61K 9/0053 (2013.01); A61K 31/4375 (2013.01); A61P 31/04 (2018.01)] 9 Claims
OG exemplary drawing
 
1. A method for the treatment of an infectious disease in a pig caused by an antibiotic-resistant bacterial strain from the genus Lawsonia, wherein the method comprises administering an effective amount of a composition comprising a berberine alkaloid and piceid, to the pig for a period of 1-6 weeks.